Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality.

De Schryver, Nicolas; Serck, Nicolas; Vinetti, Marco; Gérard, Ludovic

De Schryver, Nicolas; Serck, Nicolas; Vinetti, Marco; Gérard, Ludovic.

De Schryver N; Intensive Care Unit, Clinique Saint-Pierre, Ottignies, Belgium. Electronic address: nicolas.deschryver@cspo.be.
Serck N; Intensive Care Unit, Clinique Saint-Pierre, Ottignies, Belgium.
Vinetti M; Intensive Care Unit, Clinique Saint-Pierre, Ottignies, Belgium.
Gérard L; Department of critical care medicine. Cliniques Universitaires St-Luc, Université catholique de Louvain, Brussels, Belgium.

Int J Antimicrob Agents ; 57(1): 106254, 2021 Jan.

Article in English | MEDLINE | ID: covidwho-1065143

Subject(s)

Antiviral Agents/therapeutic use; Azithromycin/therapeutic use; COVID-19 Drug Treatment; Hydroxychloroquine/therapeutic use; SARS-CoV-2/pathogenicity; Age Factors; Anti-Bacterial Agents/therapeutic use; Antimalarials/therapeutic use; Bias; COVID-19/mortality; COVID-19/virology; Clinical Trials as Topic; Drug Combinations; Drug Repositioning; Humans; Intensive Care Units; Observational Studies as Topic; Severity of Illness Index; Survival Analysis; Uncertainty

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Azithromycin / SARS-CoV-2 / COVID-19 Drug Treatment / Hydroxychloroquine Type of study: Observational study / Prognostic study / Randomized controlled trials / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Int J Antimicrob Agents Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google